Latest news about Cymbiotika
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Cymbiotika, a leading wellness and supplement brand, has secured $30 million in debt financing led by RevTek Capital. This funding will support expansion into retail, entry into the Canadian market, enhance infrastructure and automation, and drive exponential revenue and EBITDA growth in 2025 and beyond[1][4][5].
Cymbiotika has launched a new pet line, featuring four supplements: Probiotic+, Calm, Hip & Joint, and Allergy & Immune Health. These products are formulated with premium ingredients to support optimal pet health, focusing on digestive well-being, calmness, joint health, and immune system support[2][3].
Open job positions at Cymbiotika
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Vice President of Product Development
Warehouse Associate
Procurement Project Manager

